Top segments and regional performance

Last year, the company generated ‪874.00 M‬ JPY, the most of which — ‪643.64 M‬ JPY — came from its top-performing segment, Pharmaceutical, compared to ‪23.24 M‬ JPY the previous year. The greatest contribution came from Japan, which accounted for ‪567.79 M‬ JPY last year, with ‪23.24 M‬ JPY the year before.